Tristel is set to acquire Vernagene, another chlorine dioxide specialist focusing on the water treatment and food processing industries
Tristel is to acquire Vernagene: a price of £1million has been agreed and contracts exchanged.
Completion is expected shortly.
With both companies utilising chlorine dioxide chemistry for disinfection, their operations are highly synergistic.
Tristel's product range concentrates on the provision of sterilising solutions for endoscope decontamination, and sporicidal wipes for the cleaning of hard surfaces and non-invasive medical devices.
The company has an established sales force in the UK and a rapidly growing list of overseas distributors.
Vernagene is known for the provision of large scale chlorine dioxide generating devices, and stabilised products such as those used to decrease microbial load during food processing.
With the acquisition of Vernagene, Tristel has a ready-made opportunity to expand its operations into new markets.
Vernagene already has customers in the government, municipal, industrial, food and healthcare sectors - including the provision of water treatment solutions for Legionella control to a significant number of UK hospitals.
Tristel currently supplies around 400 hospitals with its instrument and surface sterilants.
The acquisition also presents significant opportunities for cross selling - Tristel hopes to combine its patented technology and unique delivery systems with Vernagene's chlorine dioxide chemistry.
Vernagene's customer base will benefit from the added experience and support of Tristel's sales and support teams.
